Twist Bioscience filed disclosures with the SEC, listed its stock on Nasdaq, and received a rating upgrade from TD Cowen.
2 reports, 1 independent
Updated Jun 25
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Twist Bioscience filed disclosures with the SEC, listed its stock on Nasdaq, and received a rating upgrade from TD Cowen.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Twist Bioscience listed on Nasdaq and filed SEC disclosures, accompanied by a buy rating.1 source
Twist Bioscience files with the SEC, lists on Nasdaq, and benefits from a rating raise by TD Cowen.1 source
Keep exploring
The entities involved
-
Twist Bioscience
Biotechnology company
Nothing else this week.
-
SEC
Slovak company
-
TD Cowen
American investment bank
-
Nasdaq
American fully electronic stock exchange
Related events
- Twin Vee PowerCats filed required disclosures with the SEC and its stock began trading on the Nasdaq exchange.
- AMD stock is traded on Nasdaq, and the company filed disclosures with the SEC.
- First Solar, HSBC, and Nasdaq are involved in a new development: the company listed on the stock exchange and received rating upgrades and downgrades.